Intentional dietary restriction can quietly create significant micronutrient insufficiencies long before overt malnutrition becomes clinically apparent. Recognising nutrient gaps early and supporting nutritional adequacy has the potential to optimise both weight loss and health outcomes.

Maintaining Nutritional Adequacy During Weight Loss Interventions

Patients intentionally restricting food intake for obesity management typically adopt a goal-oriented, weight-loss-focused approach to dieting. As dietary variety and total caloric intake decline over extended periods, the risk of inadequate nutrient intake increases. Micronutrient concerns are therefore particularly relevant in individuals pursuing long-term weight loss through highly restrictive diets or the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro), which markedly suppress appetite. Importantly, although these patients are overweight or obese, excess body weight does not necessarily reflect nutritional adequacy.

Reduced total food intake can lower consumption of essential vitamins, minerals, protein, and fibre. This is of particular concern when patients rely heavily on convenience foods or struggle to tolerate larger meals due to medication-induced satiety or gastrointestinal symptoms. Protein intake becomes especially important during weight loss to help preserve lean mass.¹ Reduced intake of eggs and other protein-rich foods may also compromise dietary choline intake, which is important for liver function, lipid metabolism and neurological health.² Inadequate intake of magnesium, potassium and vitamin B1 among other nutrients can contribute to fatigue, muscle cramps and impaired energy production.^1,3-7 In addition, very-low-fat diets compromise intake of foods rich in fat-soluble vitamins including vitamins A, D, E, and K⁸ – deficiencies that also coincide with GLP-1 RA use, especially vitamin D.^1,3,5 Iron deficiency and calcium inadequacy are also commonly reported in GLP-1 RA users.^1,3,5

Over time, persistent micronutrient inadequacy during aggressive dieting bordering on starvation may negatively affect metabolic rate, bone health, immune function, and reproductive health, while also increasing the risk of disordered eating behaviours.⁹ Practitioners should therefore encourage nutrient density rather than calorie restriction alone, helping patients prioritise high-quality protein, colourful fibre-rich plant foods, healthy fats, dietary diversity, and regular mealtimes despite reduced appetite. The goal should be gradual, sustainable weight loss achieved while maintaining nutritional adequacy and supporting overall health.

Multinutrient Support as a Nutritional Safety Net

Given the breadth of potential nutrient insufficiencies associated with chronic dietary restriction, there is strong rationale for considering a quality multivitamin and mineral formula as part of a broader nutritional strategy. While a supplement cannot compensate for inadequate caloric intake or replace balanced meals, it may provide foundational support during periods where optimal dietary intake is unrealistic or inconsistent. This may be particularly relevant in patients with low appetite, significant food avoidance, nausea, limited dietary variety, or medically supervised weight loss interventions.

Such formulas may assist in covering common shortfalls involving B vitamins, zinc, magnesium, potassium, selenium, vitamin D, and other nutrients (e.g. iodine and vitamin C), thereby broadly supporting energy production, immune function, endocrine and neurological health, antioxidant defence, and tissue repair. For practitioners, a multivitamin and mineral formula may also serve as a practical nutritional safety net while longer term dietary and behavioural changes are implemented.

Importantly, supplementation should remain individualised, with consideration given to pathology results, medication interactions, gastrointestinal tolerance, and the patient’s overall medical picture.

Additional nutrients (e.g. omega-3 fatty acids¹⁰ and coenzyme Q10 [CoQ10]/ubiquinol)¹¹ and/or herbal adaptogens, such as Withania somnifera (Withania),¹² may also be indicated.

Closing the Gap with Care

Caloric restriction and undernourishment can coexist, particularly in the context of intentional weight loss strategies facilitated by modern pharmacotherapy. Identifying likely micronutrient gaps early and providing evidence-informed nutritional interventions, alongside other dietary and lifestyle measures, can help optimise nutritional status and support broader health outcomes beyond weight reduction alone.

References

1. Johnson B, Milstead M, Thomas O, McGlasson T, Green L, Kreider R, et al. Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study. Front Nutr. 2025 Apr;12:1566498. DOI: 10.3389/fnut.2025.1566498

2. Office of Dietary Supplements. Choline [Internet]. Bethesda: National Institutes of Health; 2022 [cited 2026 May 26]. Available from: https://ods.od.nih.gov/factsheets/Choline-HealthProfessional/

3. Urbina J, Salinas-Ruiz LE, Valenciano C, Clapp B. Micronutrient and nutritional deficiencies associated with GLP-1 receptor agonist therapy: a narrative review. Clin Obes. 2026 Feb;16(1):e70070. DOI: 10.1111/cob.70070

4. Office of Dietary Supplements. Magnesium [Internet]. Bethesda: National Institutes of Health; 2026 [cited 2026 May 26]. Available from: https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/

5. Scott Butsch W, Sulo S, Chang AT, Kim JA, Kerr KW, Williams DR, et al. Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: a retrospective observational study. Obes Pillars. 2025 Jun;15:100186. DOI: 10.1016/j.obpill.2025.100186

6. Office of Dietary Supplements. Thiamin [Internet]. Bethesda: National Institutes of Health; 2023 [cited 2026 May 26]. Available from: https://ods.od.nih.gov/factsheets/Thiamin-HealthProfessional/

7. Office of Dietary Supplements. Potassium [Internet]. Bethesda: National Institutes of Health; 2022 [cited 2026 May 26]. Available from: https://ods.od.nih.gov/factsheets/Potassium-HealthProfessional/

8. Daley SF, Goldin J. Low-fat diet [Internet]. Treasure Island: StatPearls; 2026 [cited 2026 May 26]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553097/

9. Healthline. Why starving yourself isn’t a good idea for weight loss [Internet]. San Francisco: Healthline; 2024 [cited 2026 May 26]. Available from: https://www.healthline.com/nutrition/starving-yourself

10. Albracht-Schulte K, Kalupahana NS, Ramalingam L, Wang S, Rahman SM, Robert-McComb J, et al. Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update. J Nutr Biochem. 2018 Aug;58:1-16. DOI: 10.1016/j.jnutbio.2018.02.012

11. Mantle D, Kozhevnikova S, Larsen S. Coenzyme Q10 and obesity: an overview. Antioxidants (Basel). 2025 Jul;14(7):871. DOI: 10.3390/antiox14070871

12. Pakhale K, Pakhale R, Srivathsan M, Langade J, Langade D. Efficacy and safety of ashwagandha (Withania somnifera) root extract on stress and weight management in adults: a prospective, randomized, double-blind, placebo-controlled study. J Med Life. 2025 Dec;18(12):1140-1154. DOI: 10.25122/jml-2025-0147